These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33929638)

  • 41. The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease-modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 40 randomized controlled trials.
    Zheng W; Mei Y; Chen C; Cai L; Chen H
    Phytother Res; 2021 Jun; 35(6):2902-2924. PubMed ID: 33368709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic review and meta-analysis on the efficacy of methotrexate in rheumatoid arthritis.
    Jiang X; Zeng J; Chen F; Li J
    Ann Palliat Med; 2021 Oct; 10(10):10652-10660. PubMed ID: 34763513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review.
    Downey C
    Int J Rheum Dis; 2016 Jun; 19(6):536-50. PubMed ID: 26200188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature.
    Visser K; van der Heijde D
    Ann Rheum Dis; 2009 Jul; 68(7):1094-9. PubMed ID: 19033290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis.
    Hegen M; Keith JC; Collins M; Nickerson-Nutter CL
    Ann Rheum Dis; 2008 Nov; 67(11):1505-15. PubMed ID: 18055474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis.
    Doan QV; Chiou CF; Dubois RW
    J Manag Care Pharm; 2006 Sep; 12(7):555-69. PubMed ID: 16981801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNAs in rheumatoid arthritis.
    Salehi E; Eftekhari R; Oraei M; Gharib A; Bidad K
    Clin Rheumatol; 2015 Apr; 34(4):615-28. PubMed ID: 25736037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.
    Malottki K; Barton P; Tsourapas A; Uthman AO; Liu Z; Routh K; Connock M; Jobanputra P; Moore D; Fry-Smith A; Chen YF
    Health Technol Assess; 2011 Mar; 15(14):1-278. PubMed ID: 21439251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.
    Boyce EG; Halilovic J; Stan-Ugbene O
    Clin Ther; 2010 Sep; 32(10):1681-703. PubMed ID: 21194591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Jobanputra P; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Kynaston-Pearson FJ
    Cochrane Database Syst Rev; 2014 Sep; (9):CD007649. PubMed ID: 25231904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of Guizhi-Shaoyao-Zhimu decoction in the treatment of rheumatoid arthritis: A protocol for systematic review and meta-analysis.
    Ye J; Li R; Hu Z; Zhang P; Liu L
    Medicine (Baltimore); 2021 Mar; 100(9):e24416. PubMed ID: 33655915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Summary Findings of a Systematic Literature Review of the Ultrasound Assessment of Bone Erosions in Rheumatoid Arthritis.
    Szkudlarek M; Terslev L; Wakefield RJ; Backhaus M; Balint PV; Bruyn GA; Filippucci E; Gandjbakhch F; Iagnocco A; Mandl P; Möller I; Naredo E; Schmidt WA; d'Agostino MA
    J Rheumatol; 2016 Jan; 43(1):12-21. PubMed ID: 26628596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin-Sensiting Effects of Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    Leporini C; Russo E; D Angelo S; Arturi F; Tripepi G; Peluso R; Grembiale RD; Olivieri I; De Sarro G; Ursini F
    Rev Recent Clin Trials; 2018; 13(3):184-191. PubMed ID: 29542420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
    Roubille C; Haraoui B
    Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative Efficacy and Safety of Biosimilar Rituximab and Originator Rituximab in Rheumatoid Arthritis and Non-Hodgkin's Lymphoma: A Systematic Review and Meta-analysis.
    Lee S; Lee H; Kim E
    BioDrugs; 2019 Oct; 33(5):469-483. PubMed ID: 31446557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A systematic review of viral exposures as a risk for rheumatoid arthritis.
    Kudaeva FM; Speechley MR; Pope JE
    Semin Arthritis Rheum; 2019 Feb; 48(4):587-596. PubMed ID: 29747994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-inflammatory activities of taurine chloramine: implication for immunoregulation and pathogenesis of rheumatoid arthritis.
    Kontny E; Maśliński W; Marcinkiewicz J
    Adv Exp Med Biol; 2003; 526():329-40. PubMed ID: 12908617
    [No Abstract]   [Full Text] [Related]  

  • 59. Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review.
    Gout T; Ostör AJ; Nisar MK
    Clin Rheumatol; 2011 Nov; 30(11):1471-4. PubMed ID: 21833686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rofecoxib for the treatment of rheumatoid arthritis.
    Garner S; Fidan D; Frankish R; Judd M; Towheed T; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2002; (3):CD003685. PubMed ID: 12137705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.